Superluminal Medicines
1deals in 2026
$60.0Mraised
| Date | Type | Amount | Upfront | Investors / partner | Notes | Source |
|---|---|---|---|---|---|---|
| 3 Sep 2026 | Series B | $60.0M | — | BVF Partners (lead) | Source |
| Date | Type | Amount | Upfront | Investors / partner | Notes | Source |
|---|---|---|---|---|---|---|
| 3 Sep 2026 | Series B | $60.0M | — | BVF Partners (lead) | Source |